文献速递关节外科

机器学习模型预测无菌性翻修全关节置换术后30天死亡率、心血管并发症和呼吸系统并发症

Machine-learning Models Predict 30-Day Mortality, Cardiovascular Complications, and Respiratory Complications After Aseptic Revision Total Joint Arthroplasty.
PubMed 文献 · Clin Orthop Relat Res · 2022-06-20

该研究基于美国外科医师学会国家手术质量改进计划2014至2019年数据库,纳入无菌性翻修全膝关节置换术与全髋关节置换术患者,使用XGBoost构建预测30天死亡率、心脏并发症和呼吸系统并发症的模型,并在2019年数据上进行时间验证。模型在内部验证中的c-statistic分别为0.88、0.80和0.78,在时间验证中分别为0.87、0.70和0.82;校准曲线显示预测概率略高于观察概率。作者认为该免费在线计算器可供外科医生术前使用,以向患者说明其个体术后风险。

要点

  • 模型预测无菌性翻修全关节置换术后30天死亡率、心脏并发症和呼吸系统并发症的时间验证c-statistic分别为0.87、0.70和0.82。
  • 所有模型中重要的风险因素包括年龄增加以及较高的ASA评分、BMI、血细胞比容水平和钠水平。
  • 血细胞比容低于36%以及BMI低于24 kg/m²(尤其是低于20 kg/m²)预测三种不良结局风险增加。

核心结论

  • 该时间验证模型预测无菌性翻修全髋关节置换术或全膝关节置换术后30天死亡率、心脏并发症和呼吸系统并发症,c-statistic范围为0.78至0.88。
  • 该免费风险计算器可供外科医生术前使用,以向患者说明其个体术后这些特定不良结局的风险。
  • 尚未回答的问题包括改变所研究的术前患者变量(如钠或血细胞比容)是否会影响术后不良结局风险,需要前瞻性队列研究来回答此问题。

研究设计与样本

  • 这是一项时间验证的回顾性研究,分析2014至2019年国家手术质量改进计划数据库。
  • 训练数据集为2014至2018年,2019年为验证数据集。
  • 2014至2019年间,共有24,682例患者接受无菌性翻修全膝关节置换术,17,871例患者接受无菌性翻修全髋关节置换术。
  • 基于排除不洁伤口手术,78%(19,345/24,682)的无菌性翻修全膝关节置换术和82%(14,711/17,871)的无菌性翻修全髋关节置换术符合条件。
  • 使用XGBoost创建30天不良结局评分工具,性能指标包括区分度和校准度。

主要发现

  • 模型在内部验证中预测死亡率、心脏并发症和呼吸系统并发症的c-statistic分别为0.88(95%CI 0.83至0.93)、0.80(95%CI 0.75至0.84)和0.78(95%CI 0.74至0.82)。
  • 模型在时间验证中预测死亡率、心脏并发症和呼吸系统并发症的c-statistic分别为0.87(95%CI 0.77至0.96)、0.70(95%CI 0.61至0.78)和0.82(95%CI 0.75至0.88)。
  • 校准曲线显示预测略过度自信(大多数预测概率高于观察概率)。
  • 对2020年数据的事后分析未能在2019年验证集上改善校准度。
  • 所有模型中重要的风险因素包括年龄增加以及较高的ASA评分、BMI、血细胞比容水平和钠水平;血细胞比容和ASA在所有模型中均位列前三重要特征。

关键数值与推荐

  • 死亡率和心脏并发症模型中关联最强的因素为年龄,呼吸系统模型中为慢性阻塞性肺疾病。
  • 钠相关风险呈U形曲线,术前低钠血症和高钠血症预测死亡率和呼吸系统并发症风险增加,最低点在138 mmol/L;低钠血症与死亡率的关联比高钠血症更强。
  • 血细胞比容水平低于36%预测所有三种不良结局风险增加。
  • BMI低于24 kg/m²(尤其是低于20 kg/m²)预测所有三种不良结局风险增加,较高BMI几乎无影响。

临床怎么用

  • 作者认为该免费风险计算器可供外科医生术前使用,以向患者说明其个体术后这些特定不良结局的风险。

局限性

  • 校准曲线显示预测略过度自信(大多数预测概率高于观察概率)。
  • 对2020年数据的事后分析未能在2019年验证集上改善校准度。
  • 尚未回答的问题包括改变所研究的术前患者变量(如钠或血细胞比容)是否会影响术后不良结局风险,需要前瞻性队列研究来回答此问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aseptic revision THA and TKA are associated with an increased risk of adverse outcomes compared with primary THA and TKA. Understanding the risk profiles for patients undergoing aseptic revision THA or TKA may provide an opportunity to decrease the risk of postsurgical complications. There are risk stratification tools for postoperative complications after aseptic revision TKA or THA; however, current tools only include nonmodifiable risk factors, such as medical comorbidities, and do not include modifiable risk factors. QUESTIONS/PURPOSES: (1) Can machine learning predict 30-day mortality and complications for patients undergoing aseptic revision THA or TKA using a cohort from the American College of Surgeons National Surgical Quality Improvement Program database? (2) Which patient variables are the most relevant in predicting complications? METHODS: This was a temporally validated, retrospective study analyzing the 2014 to 2019 National Surgical Quality Improvement Program database, as this database captures a large cohort of aseptic revision THA and TKA patients across a broad range of clinical settings and includes preoperative laboratory values. The training data set was 2014 to 2018, and 2019 was the validation data set. Given that predictive models learn expected prevalence of outcomes, this split allows assessment of model performance in contemporary patients. Between 2014 and 2019, a total of 24,682 patients underwent aseptic revision TKA and 17,871 patients underwent aseptic revision THA. Of those, patients with CPT codes corresponding to aseptic revision TKA or THA were considered as potentially eligible. Based on excluding procedures involving unclean wounds, 78% (19,345 of 24,682) of aseptic revision TKA procedures and 82% (14,711 of 17,871) of aseptic revision THA procedures were eligible. Ten percent of patients in each of the training and validation cohorts had missing predictor variables. Most of these missing data were preoperative sodium or hematocrit (8% in both the training and validation cohorts). No patients had missing outcome data. No patients were excluded due to missing data. The mean patient was age 66 ± 12 years, the mean BMI was 32 ± 7 kg/m 2 , and the mean American Society of Anesthesiologists (ASA) Physical Score was 3 (56%). XGBoost was then used to create a scoring tool for 30-day adverse outcomes. XGBoost was chosen because it can handle missing data, it is nonlinear, it can assess nuanced relationships between variables, it incorporates techniques to reduce model complexity, and it has a demonstrated record of producing highly accurate machine-learning models. Performance metrics included discrimination and calibration. Discrimination was assessed by c-statistics, which describe the area under the receiver operating characteristic curve. This quantifies how well a predictive model discriminates between patients who have the outcome of interest versus those who do not. Relevant ranges for c-statistics include good (0.70 to 0.79), excellent (0.80 to 0.89), and outstanding (> 0.90). We estimated 95% confidence intervals (CIs) for c-statistics by 500-sample bootstrapping. Calibration curves quantify reliability of model predictions. Reliable models produce prediction probabilities for outcomes that are similar to observed probabilities of those outcomes, so a well-calibrated model should demonstrate a calibration curve that does not deviate substantially from a line of slope 1 and intercept 0. Calibration curves were generated on the 2019 validation data. Shapley Additive Explanations (SHAP) visualizations were used to investigate feature importance to gain insight into how models made predictions. The models were built into an online calculator for ongoing testing and validation. The risk calculator, which is freely available ( http://nb-group.org/rev2/ ), allows a user to input patient data to calculate postoperative risk of 30-day mortality, cardiac, and respiratory complications after aseptic revision TKA or THA. A post hoc analysis was performed to assess whether using data from 2020 would improve calibration on 2019 data. RESULTS: The model accurately predicted mortality, cardiac complications, and respiratory complications after aseptic revision THA or TKA, with c-statistics of 0.88 (95% CI 0.83 to 0.93), 0.80 (95% CI 0.75 to 0.84), and 0.78 (95% CI 0.74 to 0.82), respectively, on internal validation and 0.87 (95% CI 0.77 to 0.96), 0.70 (95% CI 0.61 to 0.78), and 0.82 (95% CI 0.75 to 0.88), respectively, on temporal validation. Calibration curves demonstrated slight over-confidence in predictions (most predicted probabilities were higher than observed probabilities). Post hoc analysis of 2020 data did not yield improved calibration on the 2019 validation set. Important risk factors for all models included increased age and higher ASA, BMI, hematocrit level, and sodium level. Hematocrit and ASA were in the top three most important features for all models. The factor with the strongest association for mortality and cardiac complication models was age, and for the respiratory model, chronic obstructive pulmonary disease. Risk related to sodium followed a U-shaped curve. Preoperative hyponatremia and hypernatremia predicted an increased risk of mortality and respiratory complications, with a nadir of 138 mmol/L; hyponatremia was more strongly associated with mortality than hypernatremia. A hematocrit level less than 36% predicted an increased risk of all three adverse outcomes. A BMI less than 24 kg/m 2 -and especially less than 20 kg/m 2 -predicted an increased risk of all three adverse outcomes, with little to no effect for higher BMI. CONCLUSION: This temporally validated model predicted 30-day mortality, cardiac complications, and respiratory complications after aseptic revision THA or TKA with c-statistics ranging from 0.78 to 0.88. This freely available risk calculator can be used preoperatively by surgeons to educate patients on their individual postoperative risk of these specific adverse outcomes. Unanswered questions that remain include whether altering the studied preoperative patient variables, such as sodium or hematocrit, would affect postoperative risk of adverse outcomes; however, a prospective cohort study is needed to answer this question. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Abraham VM, Booth G, Geiger P, et al. Machine-learning Models Predict 30-Day Mortality, Cardiovascular Complications, and Respiratory Complications After Aseptic Revision Total Joint Arthroplasty. Clin Orthop Relat Res. 2022. PMID: 35767804. doi:10.1097/CORR.0000000000002276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。